Intratumoral B cell and interferon signatures in newly diagnosed glioblastoma are associated with longer survival in patients treated with SurVaxM

Publication Date

2025

Content Type

article

PubMed ID:

41066027

Additional Authors:

Additional Authors and Institutional Affiliations

This document is currently not available here.

Share

COinS